| dc.contributor.author | Subbaiah, C S | |
| dc.contributor.author | Haq, W | |
| dc.date.accessioned | 2014-11-14T07:16:30Z | |
| dc.date.available | 2014-11-14T07:16:30Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Tetrahedron: Asymmetry,2014, 25(13–14), 1026–1030 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/1420 | |
| dc.description.abstract | Synthesis of sitagliptin phosphate 1, a novel DPP-IV inhibitor for the treatment of type 2 diabetes mellitus has been accomplished starting from chiral synthon (1,4-bis[(R)-1-phenylethyl]piperazine-2,5-dione) 2, involving high stereocontrolled (>98%) alkylation as a key step, in a good overall yield of 50% over six steps. | en |
| dc.format.extent | 232169 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | CSIR-CDRI Communication No. 8710 | en |
| dc.subject | Sitagliptin phosphate | en |
| dc.subject | Type 2 diabetes mellitus | en |
| dc.subject | Stereocontrolled alkylation | en |
| dc.subject | Asymmetric synthesis | en |
| dc.title | Efficient Stereocontrolled Synthesis of Sitagliptin Phosphate | en |
| dc.type | Article | en |